Protein Summary
Plays a central role in late thymocyte development by controlling both positive and negative T-cell selection. Required to sustain and/or integrate signals required for proper lineage commitment and maturation of T-cells. Regulates T-cell development through T-cell antigen receptor (TCR) signaling and in particular through the regulation of calcium influx and phosphorylation of Erk. This gene encodes a protein that plays a regulatory role in both positive and negative T-cell selection during late thymocyte development. The protein functions through T-cell antigen receptor signaling, and is necessary for proper lineage commitment and maturation of T-cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
- ENST00000368248
- ENSP00000357231
- ENSG00000172673
- ENST00000368250
- ENSP00000357233
- ENST00000537166
- ENSP00000439863
- ENST00000610842
- ENSP00000480630
- ENSG00000275122
- ENST00000613862
- ENSP00000480967
- ENST00000614155
- ENSP00000484170
- ENST00000630369
- ENSP00000487358
- C6orf190
- C6orf207
- GASP
- SPOT
- TSEPA
- C6orf190
- C6orf207
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 0.65 | ||
tissue sample | 0.58 | ||
microRNA | 0.56 | ||
cellular component | 0.53 | ||
cell line | 0.51 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 17.89 (req: < 5)
Gene RIFs: 14 (req: <= 3)
Antibodies: 224 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 17.89 (req: >= 5)
Gene RIFs: 14 (req: > 3)
Antibodies: 224 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0